Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification.

Kohli RM, Maul RW, Guminski AF, McClure RL, Gajula KS, Saribasak H, McMahon MA, Siliciano RF, Gearhart PJ, Stivers JT.

J Biol Chem. 2010 Dec 24;285(52):40956-64. doi: 10.1074/jbc.M110.177402. Epub 2010 Oct 6.

2.

AID and Apobec3G haphazard deamination and mutational diversity.

Jaszczur M, Bertram JG, Pham P, Scharff MD, Goodman MF.

Cell Mol Life Sci. 2013 Sep;70(17):3089-108. doi: 10.1007/s00018-012-1212-1. Epub 2012 Nov 22. Review.

3.

Multifaceted antiviral actions of APOBEC3 cytidine deaminases.

Chiu YL, Greene WC.

Trends Immunol. 2006 Jun;27(6):291-7. Epub 2006 May 4. Review.

PMID:
16678488
4.

APOBEC family proteins: novel antiviral innate immunity.

Takaori-Kondo A.

Int J Hematol. 2006 Apr;83(3):213-6. Review.

PMID:
16720550
5.

Stochastic properties of processive cytidine DNA deaminases AID and APOBEC3G.

Chelico L, Pham P, Goodman MF.

Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):583-93. doi: 10.1098/rstb.2008.0195. Review.

6.

APOBEC deaminases-mutases with defensive roles for immunity.

Prochnow C, Bransteitter R, Chen XS.

Sci China C Life Sci. 2009 Oct;52(10):893-902. doi: 10.1007/s11427-009-0133-1. Epub 2009 Nov 13. Review.

PMID:
19911124
7.
8.

APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.

Franca R, Spadari S, Maga G.

Med Sci Monit. 2006 May;12(5):RA92-8. Review.

PMID:
16641889
9.

Reward versus risk: DNA cytidine deaminases triggering immunity and disease.

Pham P, Bransteitter R, Goodman MF.

Biochemistry. 2005 Mar 1;44(8):2703-15. Review.

PMID:
15723516
10.

Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection.

Rosenberg BR, Papavasiliou FN.

Adv Immunol. 2007;94:215-44. Review.

PMID:
17560276
11.

[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].

Fan B, Cen S, Jiang JD.

Yao Xue Xue Bao. 2008 Jul;43(7):678-82. Review. Chinese.

PMID:
18819469
12.

DNA deamination in immunity: AID in the context of its APOBEC relatives.

Conticello SG, Langlois MA, Yang Z, Neuberger MS.

Adv Immunol. 2007;94:37-73. Review.

PMID:
17560271
13.

An overview of cytidine deaminases.

Navaratnam N, Sarwar R.

Int J Hematol. 2006 Apr;83(3):195-200. Review.

PMID:
16720547
14.

Retroviral restriction by APOBEC proteins.

Harris RS, Liddament MT.

Nat Rev Immunol. 2004 Nov;4(11):868-77. Review.

PMID:
15516966
15.

The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.

Chiu YL, Greene WC.

Annu Rev Immunol. 2008;26:317-53. doi: 10.1146/annurev.immunol.26.021607.090350. Review.

PMID:
18304004
16.

Advantages and disadvantages of cytidine deamination.

Cascalho M.

J Immunol. 2004 Jun 1;172(11):6513-8. Review.

17.

The AID/APOBEC family of nucleic acid mutators.

Conticello SG.

Genome Biol. 2008;9(6):229. doi: 10.1186/gb-2008-9-6-229. Epub 2008 Jun 17. Review.

18.

Biochemical basis of immunological and retroviral responses to DNA-targeted cytosine deamination by activation-induced cytidine deaminase and APOBEC3G.

Chelico L, Pham P, Petruska J, Goodman MF.

J Biol Chem. 2009 Oct 9;284(41):27761-5. doi: 10.1074/jbc.R109.052449. Epub 2009 Aug 13. Review.

19.

[Antiviral defense by APOBEC3 family proteins].

Takaori A.

Uirusu. 2005 Dec;55(2):267-72. Review. Japanese.

20.

The biochemistry of activation-induced deaminase and its physiological functions.

Larijani M, Martin A.

Semin Immunol. 2012 Aug;24(4):255-63. doi: 10.1016/j.smim.2012.05.003. Epub 2012 Jun 12. Review.

PMID:
22695318

Supplemental Content

Support Center